The engineering of virus-like particles (VLPs) is a viable strategy for the development of
vaccines and for the identification of therapeutic targets without using live viruses. Here, we …

Recently, a great effort has been devoted to studying attenuated and subunit vaccine
development against SARS-CoV-2 since its outbreak in December 2019. It is known that …

Exosomes are emerging as potent and safe delivery carriers for use in vaccinology and
therapeutics. A better vaccine for severe acute respiratory syndrome coronavirus 2 (SARS …

Due to the insufficient long-term protection and significant efficacy reduction to new variants
of current COVID-19 vaccines, the epidemic prevention and control are still challenging …

Extracellular vesicles (EVs), which are cell released double layered membrane particles,
have been found in every circulating body fluid, and provide a tool for conveying diverse …

The development of safe and effective vaccine formulations against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) represents a hallmark in the history of vaccines …

Severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) has caused the
pandemic that began late December 2019. The co-expression of SARS-CoV-2 structural …

The authentic SARS-CoV-2 requires to be handled in Biosafety Level 3 laboratories, which
restrains investigation by the broader scientific community. Here, we report the development …

Background To investigate a vaccine technology with potential to protect against
coronavirus disease 2019 (COVID-19) and reduce transmission of severe acute respiratory …

Dear Editor, Since the outbreak of a novel coronavirus disease (COVID-19) in late 2019, it
has spread rapidly and developed into a global pandemic. As of August 12, 2020, more than …